Vident Advisory’s Medtronic MDT Stock Holding History

Vident Advisory’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.5M	Buy	98,072 +26,017	+36%	+$2.49M	0.07%	234
2025 Q4	$6.92M	Buy	72,055 +6,845	+10%	+$665K	0.06%	251
2025 Q3	$6.21M	Sell	65,210 -673	-1%	-$61.9K	0.06%	262
2025 Q2	$5.74M	Buy	65,883 +25,099	+62%	+$2.13M	0.06%	244
2025 Q1	$3.67M	Buy	40,784 +2,423	+6%	+$217K	0.05%	298
2024 Q4	$3.06M	Sell	38,361 -353	-0.9%	-$30.6K	0.05%	314
2024 Q3	$3.49M	Buy	38,714 +23,498	+154%	+$1.98M	0.09%	238
2024 Q2	$1.2M	Buy	15,216 +2,475	+19%	+$203K	0.03%	529
2024 Q1	$1.11M	Sell	12,741 -20,460	-62%	-$1.75M	0.02%	547
2023 Q4	$2.74M	Sell	33,201 -722	-2%	-$55K	0.07%	303
2023 Q3	$2.66M	Buy	+33,923	New	+$2.84M	0.08%	259

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vident Advisory's MDT Position: Q1 2026 in Review

Vident Advisory increased its Medtronic (MDT) stake by 36% in Q1 2026, buying an estimated $2.49M and bringing the position to 98,072 shares worth $8.5M. The position accounts for 0.07% of the portfolio, ranked #234.

Vident Advisory first reported a position in MDT in Q3 2023 and has held it in 11 quarters since. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Vident Advisory held 98,072 shares of Medtronic worth $8.5M as of Q1 2026.
Vident Advisory bought 26,017 Medtronic shares in Q1 2026, an estimated $2.49M.
Medtronic made up 0.07% of Vident Advisory's portfolio in Q1 2026, its #234 holding.
Vident Advisory first reported a position in Medtronic in Q3 2023 and has held it in 11 quarters since.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.